Sindic C., Van Antwerpen M.P., and Goffette S. The intrathecale humoral immune response: laboratory analysis and clinical relevance. Clin Chem Lab Med 39 (2001) 333-340
Kuhle J., Mehling M., and Regeniter A. Diagnostic moderne du liquide céphalorachidien, un aperçu. Forum Med Suisse 7 (2007) 166-174
Keir G., Luxton R.W., and Thompson E.J. Isoelectric focusing of cerebrospinal fluid immunoglobulin G: an annotated update. Ann Clin Biochem 27 (1990) 436-443
Luxton R.W., McLean B.N., and Thompson E.J. Isoelectric focusing versus quantitative measurements in the detection of intrathecal local synthesis of IgG. Clin Chim Acta 187 (1990) 297-308
Rumbach L., Grucker M., Kiesmann M., Warter J.M., and Collard M. Analyse biochimique du liquide céphalorachidien au cours de la sclérose en plaques : étude de différentes formules. Pathol Biol 36 (1988) 1217-1220
Tibbling G., Link H., and Ohman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37 (1977) 385-390
Tourtelotte W.W., and Ma B.I. Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis. Neurology 28 (1978) 76-83
Schuller E., and Sagar H.J. Central nervous system IgG synthesis in multiple sclerosis. Application of new formula. Acta Neurol Scand 67 (1983) 365-371
Reiber H., and Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 163 (1987) 319-328
Reiber H. Flow rate of cerebrospinal fluid (CSF)-a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 122 (1994) 189-203
Reiber H. The hyperbolic function: a mathematical solution of protein flux/CSF flow model for blood-CSF barrier function, a reply to the letter by S. Ohman J Neurol Sci 126 (1994) 243-245
Reiber H. Cerebrospinal fluid-physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 4 (1998) 99-107
Reiber H., Otto M., Trendelenburg C., and Wormek A. Reporting cerebrospinal fluid data: knowledge base and interpretation software. Clin Chem Lab Med 39 (2001) 324-332
Reiber H., and Peter J.B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 184 (2001) 101-122
Gillain N., Fumal A., and Minon J.-M. Bandes oligoclonales et index IgG interprété selon Reiber dans les maladies inflammatoires du système nerveux central. Immun Anal Biol Special 21 (2006) 348-356
Reiber H. Proteins in cerebrospinal fluid and blood: barriers. CSF flow rate and source-related dynamics. Restor Neurol Neurosci 21 (2003) 79-96
Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 310 (2001) 173-186
Schubert J., and Weissbrich B. Detection of virus-specific intrathecally synthesised immunoglobulin G with a fully automated enzyme immunoassay system. BMC Neurol (2007) 7-12
Andersson M., Alvarez-Germeno J., Bernardi G., Cogato I., Fredman P., Frederiksen J., et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57 (1994) 897-902
Frohman E.M., Racke M.K., and Raine C.S. Multiple Sclerosis-the plaque and its pathogenesis. N Engl J Med 354 (2006) 942-955
Mehling M., Kuhle J., and Regeniter A. 10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous system. The Neurologist 14 (2008) 60-65
Freedman M., Thompson E.J., Deisenhammer F., Giovannoni G., Grimley G., Keir J., et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. A consensus statement. Arch Neurol 62 (2005) 865-870
Davies G., Keir G., Thompson E.J., and Giovannonni G. The clinical significance of an intrathécale monoclonal immunoglobulin band. A follow up study. Neurology 60 (2003) 1163-1166
Franciotta D., Zardini E., and Lolli F. Correspondance: The clinical significance of an intrathecal monoclonal immunoglobulin band- a follow up study. Neurology 62 (2004) 675-676
Noseworthy J., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple, Sclerosis. N Engl J Med 343 (2000) 938-952
Confavreux C., Vukusic S., Moreau T., and Adeleine P. Relapses and progression of disability in multiple sclerosis. N Eng J Med 343 (2000) 1430-1438
Ransohoff R. Natalizumab for Multiple Sclerosis. N Engl J Med 356 (2007) 2622-2629
Hauser S., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., et al. B-cell depletion with Rituximab in relapsing-remitting Multiple -Sclerosis. N Engl J Med 358 (2008) 676-688
The CAMMS223 Trial Investigators. Alemtuzumab vs. Interféron beta-1a in early multiple sclerosis. N Eng J Med 2008; 359:1786-801.
Hauser S. Multiple lessons for Multiple Sclerosis. N Engl J Med 359 (2008) 1838-1841
Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.-P., Kappos L., et al. Diagnostic criteria for Multiple Sclerosis: 2005 revisions to the "McDonald criteria". Ann Neurol 58 (2005) 840-846
Link H., and Huang Y.M. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 180 (2006) 17-28
Sindic C.J.M., and Laterre E.C. Oligoclonal free kappa and lambda bands in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases- an immunoaffinity-mediated capillary blot study. J Neuroimmunol 33 (1991) 63-72
Villar L.M., Masjuan J., Gonzalez-Porqué P., Plaza J., Sabada M., Roldan E., et al. Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis. Ann Neurol 53 (2003) 222-226
Mandriolo J., Sola P., Bedin R., Gambini M., and Merelli E. A multifactorial prognostic index in multiple sclerosis: cerebrospnal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease. J Neurol 255 (2008) 1023-1031
Schneider R., Euler B., and Rauer S. Intrathecal IgM-synthesis does not correlate with the risk of relapse in patients with a primary demyelinating event. Eur J Neurol 14 (2007) 904-911
Reindl M., Linington C., Brehm U., Egg R., Dilitz E., Deisenhammer F., et al. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and the other neurological diseases: a comparative study. Brain 122 (1999) 2047-2056
Petereit H.F., and Reske D. Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients-follow-up and clinical implications. Cerebrospin Fluid Res 2 (2005) 3
Fateh-Moghadam. Logiciel d'aide à l'interprétation du bilan protéique du LCR. Copyright Behringwerke 1990.
Reiber H., Thompson E.J., Grimley G., Bernardi G., Adam P., Monteiro de Almeida S., et al. Quality assurance for cerebrospinal fluid protein analysis: international consensus by an internet based discussion. Clin Chem Lab Med 41 (2003) 331-337
Marshall WJ, Bangert S, Raynaud E. Paramètres biochimiques en medicine clinique. In: Biochimie médicale. Physiologie et diagnostic. Elsevier ; 2004, 10.
Lavoie E. Poser le diagnostic clinique de la pharyngite streptococcique : résultats d'une méta analyse. Actualité médicale, mai 2001 http://cetp.fmed.ulaval.ca/CetP/contenu/ARTICLES/2001/01_05_16_2.htm.
